• Profile
Close

Metabolomics identifies a biomarker revealing in vivo loss of functional ß-cell mass before diabetes onset

Diabetes Sep 29, 2019

Li L, Krznar P, Erban A, et al. - In the asymptomatic prediabetic stage, researchers conducted this investigation to identify novel plasma biomarkers for loss of functional ß-cell mass. Non-targeted and targeted metabolomics have been applied on both lean ß-Phb2-/- mice and obese db/db mice, two distinct mouse models that do not require either chemical or dietary treatments to induce spontaneous decline of functional ß-cell mass promoting progressive diabetes development. The authors identified 1,5-anhydroglucitol associated with the loss of functional ß-cell mass and uncovered metabolic similarities between liver and plasma, providing insights into the systemic impacts induced by early decrease in ß-cells.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay